Now scheduling COVID-19 vaccine appointments for ages 12+
The LEADS study is an observational research study. Approximately 500 participants with early onset cognitive impairment, and 100 cognitively normal participants, will be enrolled at 15 sites throughout the United States. Participants with early-onset cognitive impairment will attend three study visits over two years, and cognitively normal participants will participate in two visits over one year. Study activities include:
The purpose of the LEADS study is to explore the development of early-onset Alzheimer’s disease and how it compares to the more common late-onset Alzheimer’s disease. Better understanding of this form of the disease may ultimately lead to more effective treatments.
Both those with early-onset cognitive impairment (including Mild Cognitive Impairment due to Alzheimer’s disease) and those without Alzheimer’s can participate in LEADS. You may be eligible if:
If you are interested in learning more about the LEADS study, please call (401) 455-6402 or send an e-mail to memory@butler.org. Ask about the “LEADS study.”
Click here to subscribe to our monthly Memory Matters e-newsletter >>
If you are interested in learning more about this study, please fill out the form below.
Organization
Butler Hospital
Area of Study
Memory and Aging
Status
Active
Copyright © 2023 Care New England Health System